Exercise Preconditioning Provides Long-Term Protection Against Early Chronic Doxorubicin Cardiotoxicity

Abstract

Acute doxorubicin (DOX) cardiotoxicity can be attenuated by exercise preconditioning, but little is known of whether this cardioprotection continues beyond 10 days post-DOX administration. The purpose of this study was to determine the effects of exercise preconditioning on early chronic DOX-induced cardiotoxicity. Male rats were randomly assigned to sedentary, treadmill, or wheel running groups. Treadmill and wheel running animals participated in a progressive treadmill training protocol or voluntary wheel running, respectively, for 10 weeks. Following the intervention, animals were further randomized to receive either DOX (sedentary + DOX, treadmill + DOX, wheel running + DOX) or saline (sedentary + saline, treadmill + saline, wheel running + saline). All animals then remained sedentary for 4 weeks. A 22% reduction in fractional shortening was observed in left ventricles from previously sedentary animals receiving DOX when compared with sedentary + saline. This degree of decline was not observed in treadmill + DOX and wheel running + DOX. Sedentary + DOX possessed significantly depressed mitral and aortic valve blood flow velocities when compared with sedentary + saline, but these decrements were not observed in treadmill + DOX and wheel running + DOX. Ex vivo analysis revealed that left ventricular developed pressure and maximal rate of pressure development were significantly lower in sedentary + DOX when compared to sedentary + saline. Treadmill and wheel running prior to DOX treatment protected against these decrements. Exercise cardioprotection was associated with preserved myosin heavy chain but not sarcoendoplasmic reticulum Ca²⁺ ATPase 2a expression. In conclusion, 10 weeks of prior exercise protected against early chronic DOX cardiotoxicity suggesting that training status may be a determining factor in the degree of late-onset cardiotoxicity experienced by cancer patients undergoing treatment with DOX.

Keywords

anthracycline cardiomyopathy heart failure myosin heavy chain SERCA2a

References

Bernstein D. , Fajardo G. , Zhao M. , et al. Differential cardioprotective/cardiotoxic effects mediated by beta-adrenergic receptor subtypes. Am J Physiol Heart Circ Physiol. 2005;289:H2441-H2449.

Chicco AJ , Schneider CM , Hayward R. Exercise training attenuates acute doxorubicin-induced cardiac dysfunction . J Cardiovasc Pharmacol. 2006;47:182-189.

Hydock DS , Lien CY , Schneider CM , Hayward R. Exercise preconditioning protects against doxorubicin-induced cardiac dysfunction . Med Sci Sports Exerc. 2008;40:808-817.

Lipshultz SE , Lipsitz SR , Sallan SE , et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia . J Clin Oncol. 2005;23:2629-2636.

Simunek T. , Sterba M. , Popelova O. , Adamcova M. , Hrdina R. , Gersl V. Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep . 2009;61:154-171.

Arnolda L. , McGrath B. , Cocks M. , Sumithran E. , Johnston C. Adriamycin cardiomyopathy in the rabbit: an animal model of low output cardiac failure with activation of vasoconstrictor mechanisms. Cardiovasc Res. 1985;19:378-382.

Hayward R. , Hydock DS Doxorubicin cardiotoxicity in the rat: an in vivo characterization. J Am Assoc Lab Anim Sci. 2007;46:20-32.

Cole MP , Chaiswing L. , Oberley TD , et al. The protective roles of nitric oxide and superoxide dismutase in adriamycin-induced cardiotoxicity. Cardiovasc Res. 2006;69:186-197.

Alyane M. , Kebsa LB , Boussenane HN , Rouibah H. , Lahouel M. Cardioprotective effects and mechanism of action of polyphenols extracted from propolis against doxorubicin toxicity. Pak J Pharm Sci . 2008;21:201-209.

10.

Hydock DS , Lien CY , Hayward R. Anandamide preserves cardiac function and geometry in an acute doxorubicin cardiotoxicity rat model. J Cardiovasc Pharmacol Ther. 2009;14:59-67.

11.

Ramond A. , Sartorius E. , Mousseau M. , Ribuot C. , Joyeux-Faure M. Erythropoietin pretreatment protects against acute chemotherapy toxicity in isolated rat hearts. Exp Biol Med (Maywood ). 2008;233:76-83.

12.

Cusack BJ , Gambliel H. , Musser B. , et al. Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism. Cancer Chemother Pharmacol. 2006;58:517-526.

13.

Tesoriere L. , Ciaccio M. , Valenza M. , et al. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality. J Pharmacol Exp Ther. 1994;269:430-436.

14.

Berthiaume JM , Oliveira PJ , Fariss MW , Wallace KB Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction. Cardiovasc Toxicol. 2005;5:257-267.

15.

Riad A. , Bien S. , Westermann D. , et al. Pretreatment with statin attenuates the cardiotoxicity of doxorubicin in mice. Cancer Res. 2009;69:695-699.

16.

Chao HH , Liu JC , Hong HJ , Lin JW , Chen CH , Cheng TH L-carnitine reduces doxorubicin-induced apoptosis through a prostacyclin-mediated pathway in neonatal rat cardiomyocytes [published online ahead of print June 24, 2009]. Int J Cardiol. doi:10.1016/j.ijcard.2009.06.010.

17.

Todorova VK , Kaufmann Y. , Hennings L. , Klimberg VS Oral glutamine protects against acute doxorubicin-induced cardiotoxicity of tumor-bearing rats. J Nutr. 2010;140: 44-48.

18.

Abu-Khalaf MM , Juneja V. , Chung GG , et al. Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer. Breast Cancer Res Treat. 2007;104:341-349.

19.

Pein F. , Sakiroglu O. , Dahan M. , et al. Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy . Br J Cancer. 2004;91:37-44.

20.

Quiles JL , Huertas JR , Battino M. , Mataix J. , Ramirez-Tortosa MC Antioxidant nutrients and adriamycin toxicity. Toxicology . 2002;180:79-95.

21.

Hydock DS , Wonders KY , Schneider CM , Hayward R. Voluntary wheel running in rats receiving doxorubicin: effects on running activity and cardiac myosin heavy chain. Anticancer Res. 2009;29:4401-4407.

22.

de Beer EL , Bottone AE , van Der Velden J. , Voest EE Doxorubicin impairs crossbridge turnover kinetics in skinned cardiac trabeculae after acute and chronic treatment. Mol Pharmacol. 2000;57:1152-1157.

23.

Herron TJ , Korte FS , McDonald KS Loaded shortening and power output in cardiac myocytes are dependent on myosin heavy chain isoform expression. Am J Physiol Heart Circ Physiol . 2001;281:H1217-H1222.

24.

Maeda A. , Honda M. , Kuramochi T. , Takabatake T. A calcium antagonist protects against doxorubicin-induced impairment of calcium handling in neonatal rat cardiac myocytes. Jpn Circ J. 1999;63:123-129.

25.

Mijares A. , Lopez JR L-carnitine prevents increase in diastolic [Ca2+] induced by doxorubicin in cardiac cells. Eur J Pharmacol. 2001;425:117-120.

26.

Olson RD , Gambliel HA , Vestal RE , Shadle SE , Charlier HA Jr , Cusack BJ Doxorubicin cardiac dysfunction: effects on calcium regulatory proteins, sarcoplasmic reticulum, and triiodothyronine. Cardiovasc Toxicol. 2005;5:269-283.

27.

Arai M. , Yoguchi A. , Takizawa T. , et al. Mechanism of doxorubicin-induced inhibition of sarcoplasmic reticulum Ca(2+)ATPase gene transcription. Circ Res. 2000;86:8-14.

28.

Kanter MM , Hamlin RL , Unverferth DV , Davis HW , Merola AJ Effect of exercise training on antioxidant enzymes and cardiotoxicity of doxorubicin . J Appl Physiol. 1985;59:1298-1303.

29.

Chicco AJ , Hydock DS , Schneider CM , Hayward R. Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity. J Appl Physiol. 2006; 100:519-527.

30.

Talmadge RJ , Roy RR Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. J Appl Physiol. 1993;75:2337-2340.

31.

Bradford MM A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.

32.

Aragno M. , Mastrocola R. , Medana C. , et al. Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes. Endocrinology. 2006;147:5967-5974.

33.

French JP , Quindry JC , Falk DJ , et al. Ischemia-reperfusion-induced calpain activation and SERCA2a degradation are attenuated by exercise training and calpain inhibition. Am J Physiol Heart Circ Physiol. 2006;290:H128-H136.

34.

Emter CA , McCune SA , Sparagna GC , Radin MJ , Moore RL Low-intensity exercise training delays onset of decompensated heart failure in spontaneously hypertensive heart failure rats. Am J Physiol Heart Circ Physiol. 2005;289:H2030-H2038.

35.

Edes IF , Toth A. , Csanyi G. , et al. Late-stage alterations in myofibrillar contractile function in a transgenic mouse model of dilated cardiomyopathy (Tgalphaq*44). J Mol Cell Cardiol. 2008;45:363-372.

36.

Zhong Y. , Reiser PJ , Matlib MA Gender differences in myosin heavy chain-beta and phosphorylated phospholamban in diabetic rat hearts. Am J Physiol Heart Circ Physiol. 2003;285:H2688-H2693.

37.

Krenz M. , Sanbe A. , Bouyer-Dalloz F. , et al. Analysis of myosin heavy chain functionality in the heart. J Biol Chem. 2003;278:17466-17474.

38.

Korte FS , Herron TJ , Rovetto MJ , McDonald KS Power output is linearly related to MyHC content in rat skinned myocytes and isolated working hearts. Am J Physiol Heart Circ Physiol. 2005;289:H801-H812.

39.

Herron TJ , McDonald KS Small amounts of alpha-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments. Circ Res. 2002;90:1150-1152.

40.

Tardiff JC , Hewett TE , Factor SM , Vikstrom KL , Robbins J. , Leinwand LA Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. Am J Physiol Heart Circ Physiol. 2000; 278:H412-H419.

41.

Oliveira PJ , Wallace KB Depletion of adenine nucleotide trans-locator protein in heart mitochondria from doxorubicin-treated rats-relevance for mitochondrial dysfunction. Toxicology. 2006 ;220:160-168.

42.

Morris GS , Prevost MC , Nelson AG Morderate diabetes alters myosin isoenzyme distribution in cardiac but not skeletal muscle of male rats. Life Sci. 1996 ;58:833-838.

43.

Nousiainen T. , Jantunen E. , Vanninen E. , Hartikainen J. Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients. Br J Cancer. 2002;86:1697-1700.

44.

Konorev EA , Vanamala S. , Kalyanaraman B. Differences in doxorubicin-induced apoptotic signaling in adult and immature cardiomyocytes. Free Radic Biol Med. 2008; 45:1723-1728.

45.

Ueno M. , Kakinuma Y. , Yuhki K. , et al. Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo. J Pharmacol Sci. 2006;101:151-158.

46.

Jang YM , Kendaiah S. , Drew B. , et al. Doxorubicin treatment in vivo activates caspase-12 mediated cardiac apoptosis in both male and female rats. FEBS Lett . 2004;577:483-490.

47.

Zhang YW , Shi J. , Li YJ , Wei L. Cardiomyocyte death in doxorubicin-induced cardiotoxicity. Arch Immunol Ther Exp (Warsz). 2009 ;57:435-445.

48.

Park KH , Kim SY , Gul R. , et al. Fatty acids ameliorate doxorubicin-induced intracellular Ca2+ increase and apoptosis in rat cardiomyocytes. Biol Pharm Bull . 2008;31:809-815.

49.

Kim SY , Kim SJ , Kim BJ , et al. Doxorubicin-induced reactive oxygen species generation and intracellular Ca2+ increase are reciprocally modulated in rat cardiomyocytes. Exp Mol Med. 2006;38:535-545.

50.

Takaseya T. , Ishimatsu M. , Tayama E. , Nishi A. , Akasu T. , Aoyagi S. Mechanical unloading improves intracellular Ca2+ regulation in rats with doxorubicin-induced cardiomyopathy. J Am Coll Cardiol. 2004;44:2239-2246.

51.

Corapcioglu F. , Sarper N. , Berk F. , Sahin T. , Zengin E. , Demir H. Evaluation of anthracycline-induced early left ventricular dysfunction in children with cancer: a comparative study with echocardiography and multigated radionuclide angiography. Pediatr Hematol Oncol. 2006;23:71-80.

52.

Iarussi D. , Pisacane C. , Indolfi P. , Casale F. , Martino V. , Di Tullio MT Evaluation of left ventricular function in long-term survivors of childhood Hodgkin disease. Pediatr Blood Cancer. 2005 ;45:700-705.

53.

Chicco AJ , Schneider CM , Hayward R. Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart. Am J Physiol Regul Integr Comp Physiol. 2005;289:R424-R431.

54.

Ascensao A. , Magalhaes J. , Soares J. , et al. Endurance training attenuates doxorubicin-induced cardiac oxidative damage in mice. Int J Cardiol. 2005;100:451-460.

55.

Jin H. , Yang R. , Li W. , et al. Effects of exercise training on cardiac function, gene expression, and apoptosis in rats. Am J Physiol Heart Circ Physiol. 2000;279:H2994-H3002.

56.

Dudnakova TV , Lakomkin VL , Tsyplenkova VG , Shekhonin BV , Shirinsky VP , Kapelko VI Alterations in myocardial cytoskeletal and regulatory protein expression following a single doxorubicin injection. J Cardiovasc Pharmacol. 2003;41:788-794.

57.

Andersson KB , Birkeland JA , Finsen AV , et al. Moderate heart dysfunction in mice with inducible cardiomyocyte-specific excision of the Serca2 gene. J Mol Cell Cardiol. 2009;47:180-187.

58.

Barry WH Molecular inotropy: a future approach to the treatment of heart failure? Circulation. 1999;100:2303-2304.

59.

Mayosi BM , Kardos A. , Davies CH , et al. Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure. Heart. 2006;92:105-109.

60.

Lu L. , Mei DF , Gu AG , et al. Exercise training normalizes altered calcium-handling proteins during development of heart failure. J Appl Physiol. 2002;92:1524-1530.

61.

Shao CH , Wehrens XH , Wyatt TA , et al. Exercise training during diabetes attenuates cardiac ryanodine receptor dysregulation. J Appl Physiol. 2009 ;106:1280-1292.

62.

Noble EG , Moraska A. , Mazzeo RS , et al. Differential expression of stress proteins in rat myocardium after free wheel or treadmill run training. J Appl Physiol . 1999;86:1696-1701.